Atria Investments LLC Agios Pharmaceuticals, Inc. Transaction History
Atria Investments LLC
- $7.56 Billion
- Q3 2024
A detailed history of Atria Investments LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 10,628 shares of AGIO stock, worth $571,573. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,628
Previous 7,210
47.41%
Holding current value
$571,573
Previous $310,000
52.26%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
234Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$304 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$298 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$261 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$201 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$152 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.95B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...